Scott
Unfollow Follow Scott
Ex-Pfizer and Lipitor drug developer closes $33 million funding round... annarbor.com
When Roger Newton started the first Esperion Therapeutics in 1998, he raised more than $200 million and sold his company to Pfizer for $1.3 billion. Now in its second life, the Plymouth Township-based drug development company...
1 day ago Close viewer